Skip to main content

Press Releases

Note: Click on the header titles below to expand or collapse an accordion panel.
  • Red Panda
    U.S. Army medical team helps Smithsonian National Zoo to protect endangered Red Pandas (13-Dec)
    A U.S. Army medical team contributed to an investigation into the cause of death of a Red Panda at the Smithsonian's National Zoo and Conservation Biology Institute (NZCBI). Continue Reading »
  • Angiotensin-converting enzyme 2 (ACE2) protein
    Researchers Detect Monkeypox Virus in Testes of Nonhuman Primate Survivors (17-Oct)
    For the first time, scientists have detected monkeypox virus in the testes of macaques during the acute phase of infection, according to research published online today in the journal Nature Microbiology. In addition, the team found preliminary evidence of persistent infection in two animals that survived challenge with the virus. Their results highlight the potential for sexual transmission of the virus in humans. Continue Reading »
  • Monkeypox virus infection
    Messenger RNA Technology Could Be Used to Develop Infectious Disease Therapeutics (7-Jul)
    Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)–the technology recently used in COVID-19 vaccines and others–could also be used to develop treatments for infectious diseases. Their work appears in the June 2022 issue of the journal Molecular Therapy Nucleic Acids, published by Cell Press. Continue Reading »
  • Crimean-Congo hemorrhagic fever
    Research Sheds Light on Crimean-Congo Hemorrhagic Fever Disease Process (20-May)
    Army scientists determined that the body's own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans. Their work, published in today's edition of PLOS Pathogens, provides a deeper understanding of how the virus causes disease and forms a basis for developing medical countermeasures to prevent and treat infection. Continue Reading »
  • Viral membrane
    Antibody Shows Promise for Developing Hantavirus Treatment (21-Mar)
    An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according to a study published online Mar. 16 in Science Translational Medicine. Based on their initial results, the antibody appears to be a promising candidate for developing a "pan-hantavirus" therapy to protect against outbreaks caused by multiple types of known or emerging hantaviruses. Continue Reading »
  • Ebola virus (brown)
    Study Reveals Ebola Virus Can Hide in Brain, Persist Even After Treatment (9-Feb)
    In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease–even long after treatment with monoclonal antibodies. Their research, using a nonhuman primate model of Ebola virus infection, appears on the cover of today's edition of Science Translational Medicine. Continue Reading »
  • Angiotensin-converting enzyme 2 (ACE2) protein
    Scientists Develop First Lethal Hamster Model for COVID-19 (25-Jan)
    Army scientists, in collaboration with Utah State University, have developed a lethal hamster model for SARS-CoV-2, the virus that causes COVID-19. This model system will aid in understanding the severe disease course of COVID-19–including the virus's interaction with the central nervous system–and will support the advancement of vaccines and therapeutics targeting the virus. Continue Reading »
  • Capsule removal from Bacillus anthracis
    Experimental Treatment with Enzyme Protects Mice from Lethal Anthrax Infection (8-Dec)
    Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with the deadly disease. Their findings, published in today's online edition of Science Translational Medicine, suggest a potential therapeutic strategy for treating multidrug-resistant strains of anthrax, and could lead to new treatments for other bacterial infections. Continue Reading »
  • Hantavirus STM
    Gene Sequencing Tools Pinpoint Origins of Bundibugyo Virus Disease Outbreak (28-Jul)

    New research sheds light on the origins of a 2012 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo, according to a report published online this week in the journal Cell Reports Medicine. The work also demonstrates the importance of using high throughput sequencing to understand virus "spillover" events in order to more effectively manage disease outbreaks. Continue Reading »

  • Scientists Develop Novel Therapy for Crimean-Congo Hemorrhagic Fever Virus (1-Jun)
    Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent of those infected. Their results are published online today in the journal Cell. Continue Reading »
  • Scientists Establish Multiple Primate Models of SARS-CoV-2 Airborne Infection (4-Feb)
    Army scientists evaluated three nonhuman primate species as potential models of SARS-CoV-2 airborne infection, according to results published online this week in PLOS ONE. Their work demonstrates that any of these species may be useful for testing vaccines and therapies in response to the COVID-19 pandemic, which has resulted in over 104 million cases and more than 2 million deaths worldwide in the past year. Continue Reading »

Last Modified Date: 28-Feb-2024